Agave Fructans as a Carbon Source to Develop a Postbiotic-Based Strategy for the Prophylaxis and Treatment of Helicobacter pylori Infection
Authors:
- Enrique A. Sanhueza-CarreraEnrique A. Sanhueza-Carrera
- Natalia C. Hernández-DelgadoNHNatalia C. Hernández-Delgado
- Carolina Romo-GonzálezCRCarolina Romo-González
- César Castro-De la MoraCMCésar Castro-De la Mora
- Claudia Mendoza-CamachoCMClaudia Mendoza-Camacho
- Cynthia Fernández-LainezCynthia Fernández-Lainez
- Gabriel López-VelázquezGabriel López-Velázquez
Open Access
- 17 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11119
Abstract
Helicobacter pylori is a Gram-negative bacterium that inhabits the gastric mucosa and infects over 50% of the global population, predominantly in developing countries. The organism causes chronic gastritis and is associated with gastric carcinoma. Traditional antibiotic treatment promotes intestinal dysbiosis and antimicrobial resistance. In this context, postbiotics—the metabolic end products of probiotics—have been shown to be powerful antimicrobial alternatives. The excretion/secretion (E/S) products and exopolysaccharides (EPSs) of lactic acid bacteria (LAB) have been found to exhibit inhibitory activity against pathogens. EPSs are complex sugar polymers involved in biofilm formation and stress resistance, and their activity varies with culture conditions. Most notably, no digestible carbohydrates, such as those present in agave-derived Graminan-Type fructans (GTFs), are effective carbon sources for LAB, which, in turn, affects their metabolic end products. In this study, the E/S products and EPSs of the INP_MX_001 LAB strain were assayed for antimicrobial and antibiofilm activity after growth with three structurally different GTFs. Results indicated potent inhibition of H. pylori survival and biofilm formation in vitro. Our results confirm the promise of using LAB-derived postbiotics, particularly those produced with GTFs, as a novel, non-antibiotic means of combating H. pylori colonization and infection.Keywords
Funding Information
- This work was supported by the program E022 of the Instituto Nacional de Pediatría, (2024/060)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (CF-2023-I-42)
This publication has 77 references indexed in Scilit:
- Identification and ultrasensitive quantification of H. pylori infections on gastric and stool human samples with a photonic label-free nanobiosensorBiosensors and Bioelectronics, 2025
- The effect of altered pH growth conditions on the production, composition, and proteomes of Helicobacter pylori outer membrane vesiclesProteomics, 2023
- Exopolysaccharide from Lactococcus hircilactis CH4 and Lactobacillus delbrueckii GRIPUMSK as new therapeutics to treat biofilm pathogens, oxidative stress and human colon adenocarcinomaInternational Journal of Biological Macromolecules, 2023
- β(2 → 1)-β(2 → 6) and β(2 → 1) fructans protect from impairment of intestinal tight junction's gene expression and attenuate human dendritic cell responses in a fructan-dependent fashionCarbohydrate Polymers, 2023
- Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative reviewEuropean Journal of Pediatrics, 2022
- Antibiofilm efficacy of Leuconostoc mesenteroides J.27-derived postbiotic and food-grade essential oils against Vibrio parahaemolyticus, Pseudomonas aeruginosa, and Escherichia coli alone and in combination, and their application as a green preservative in the seafood industryFood Research International, 2022
- Efficient isolation of membrane-associated exopolysaccharides of four commercial bifidobacterial strainsCarbohydrate Polymers, 2022
- Feruloylated oligosaccharides and ferulic acid alter gut microbiome to alleviate diabetic syndromeFood Research International, 2020
- Primera encuesta nacional sobre el diagnóstico de la infección por Helicobacter pylori en los laboratorios de microbiología clínica en EspañaEnfermedades Infecciosas y Microbiología Clínica, 2020
- Effect of pH in the survival of Lactobacillus salivarius strain UCO_979C wild type and the pH acid acclimated variantElectronic Journal of Biotechnology, 2015